Evidence map›Paper›PMID 34946072›Full record

ArticleMicroorganisms2021

Classification of In Vitro Phage-Host Population Growth Dynamics.

Patricia E Sørensen, Duncan Y K Ng, Luc Duchateau, Hanne Ingmer, An Garmyn, Patrick Butaye

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Quantifying phage infectivity from characteristics of bacterial population dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Enhanced suppression ofAntimicrobial agents and chemotherapy · 2025
    Article
  7. Article
  8. Isolation and Characterization of Six NovelPHAGE (New Rochelle, N.Y.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Patricia E SørensenDepartment of Pathobiology, Pharmacology and Zoological Medicine, Ghent University, 9820 Merelbeke, Belgium.ORCID 0000-0003-1798-2859
Duncan Y K NgDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, 2300 Copenhagen, Denmark.ORCID 0000-0003-1561-8244
Luc DuchateauBiometrics Research Center, Ghent University, 9820 Merelbeke, Belgium.
Hanne IngmerDepartment of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark.
An GarmynDepartment of Pathobiology, Pharmacology and Zoological Medicine, Ghent University, 9820 Merelbeke, Belgium.
Patrick ButayeDepartment of Pathobiology, Pharmacology and Zoological Medicine, Ghent University, 9820 Merelbeke, Belgium.
Ghent University · BERoss University School of Veterinary Medicine · KNStatens Serum Institut · DKUniversity of Copenhagen · DK

Funding

European Union's Horizon 2020 research and innovation program 765147
6 · The paper itself

Abstract

The therapeutic use of bacteriophages (phage therapy) represents a promising alternative to antibiotics to control bacterial pathogens. However, the understanding of the phage-bacterium interactions and population dynamics seems essential for successful phage therapy implementation. Here, we investigated the effect of three factors: phage species (18 lytic

Indexed as

bacteriophageEscherichia coligrowth dynamicsphage–host interactionphage therapy

Identifiers

PMID34946072
PMCPMC8708399
OpenAlexW3217159606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.